Abstract
Background: Recently it has been shown that elevated NTProBNP levels were associated with more severe CAD, slower blood flow in culprit artery and more proximal lesions in the coronary artery. Outcomes following PCI depend upon lesion morphology and slow/noreflow phenomenon which occurs in 5–25% cases. Various risk scores, e.g. MAYO risk score have been devised to predict outcome after PCI, however data comparing NTProBNP levels with various risk scores especially in the setting of slow/noreflow are lacking.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
